Related Experiment Video
Updated: Feb 5, 2026

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
Published on: November 14, 2018
In Vitro Antimycobacterial Activities of Short Peptide-Functionalized Silver Nanoparticle and Its In Silico
Uday Suryakanta1, Sourav Mishra1, Ajit Kumar Dhal1
1School of Biotechnology, KIIT Deemed to be University, Bhubaneswar, Odisha 751024, India.
Abstract:
The rise of drug-resistant microbes has made antimicrobial therapy increasingly challenging, and despite several reports on peptide-functionalized silver nanoparticles, their efficacy against Mycobacterium species remains largely unexplored. In this study, we synthesized short peptide functionalized silver nanoparticles to develop an effective antimycobacterial agent, where peptides acted as both reducing and stabilizing agents for the one-pot synthesis of silver nanoparticles (AgNPs). The developed nanoparticles were characterized by high-resolution transmission electron microscopy (HR-TEM), dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FTIR), and UV-visible spectroscopy (UV-vis). The positively charged peptide-capped silver nanoparticles exhibited significant antimycobacterial activity against acid-fast mycobacterial strains, including Mycobacterium smegmatis, Mycobacterium bovis, and Mycobacterium marinum, compared to peptides alone, which could be due to the integrated effect of the peptide-functionalized AgNPs. Among the synthesized nanoparticles, linear peptide 2 (LP 2) functionalized AgNP exhibited the highest antimycobacterial efficacy against the Mycobacterium strains, with the lowest MIC (5 μM). AgNP LP 2 was found to be efficient to penetrate the mycobacterial cell wall, inducing membranolytic activity, triggering oxidative stress and degrading DNA, which led to the death of mycobacterial cells. Molecular docking and molecular dynamics (MD) simulations of the peptides with key enzyme FadD32 (MsmFadD32), Mycobacterium smegmatis, demonstrated strong interactions near the active site cleft, indicating potential inhibition of the mycolic acid biosynthesis pathway by the LP 2 peptide. This disruption likely challenges the organism's pathogenicity and supports the peptides' role in contributing to membranolytic activity. Additionally, AgNP LP 2 demonstrated the ability to inhibit biofilm formation and effectively disrupt preformed mycobacterial biofilms while exhibiting negligible cytotoxicity toward human embryonic kidney (HEK293) cells. In summary, our results suggest that newly developed AgNPs exhibit antimycobacterial activity without compromising the cell viability of normal cells, making them highly potent as prospective antimycobacterial agents.
Insights
Researchers developed peptide-functionalized silver nanoparticles (AgNPs) showing potent antimycobacterial activity against various Mycobacterium strains. These novel AgNPs effectively kill bacteria by disrupting cell walls and DNA, while remaining safe for human cells.
Area of Science:
- Nanotechnology
- Microbiology
- Biochemistry
Background:
- Antimicrobial resistance poses a significant global health challenge.
- Efficacy of peptide-functionalized silver nanoparticles (AgNPs) against Mycobacterium species is largely unexplored.
- Development of novel antimycobacterial agents is crucial.
Purpose of the Study:
- To synthesize and characterize peptide-functionalized AgNPs as potential antimycobacterial agents.
- To evaluate the efficacy of these AgNPs against various Mycobacterium strains.
- To investigate the mechanism of action and safety profile of the developed AgNPs.
Main Methods:
- One-pot synthesis of AgNPs using peptides as reducing and stabilizing agents.
- Characterization using HR-TEM, DLS, FTIR, and UV-vis spectroscopy.
- Antimycobacterial activity testing, minimum inhibitory concentration (MIC) determination, cytotoxicity assays, molecular docking, and molecular dynamics simulations.
Main Results:
- Positively charged peptide-capped AgNPs demonstrated significant antimycobacterial activity.
- Linear peptide 2 (LP 2) functionalized AgNP showed the highest efficacy (MIC of 5 μM).
- AgNP LP 2 induced cell death via membranolysis, oxidative stress, and DNA degradation, inhibited biofilm formation, and showed negligible cytotoxicity to HEK293 cells.
Conclusions:
- Peptide-functionalized AgNPs are effective antimycobacterial agents.
- LP 2 functionalized AgNP exhibits potent activity through multiple mechanisms.
- These novel AgNPs represent promising candidates for future antimycobacterial therapies with a favorable safety profile.
Related Concept Videos
Peptide Bonds
Short-distance Transport of Resources
Mechanistic Models: Overview of Compartment Models
Power System Three-Phase Short Circuits
Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...

